BMI View: Vietnam’s pharmaceutical and healthcare sectors are set to see strong growth, albeit from a low base, given our bullish outlook on the economy and expectations for the population’s affluence to rise. In addition, the government is committed to implementing universal healthcare coverage. The plan, while ambitious, will provide growth opportunities for pharmaceutical firms. As the scheme is implemented, patients will have increased access to medical services. Nevertheless, we highlight that a key downside risk to our view is the existence of rampant corruption. Headline Expenditure Projections ? Pharmaceuticals: VND59,214bn (US$2.84bn) in 2012 to VND69,151bn (US$3.31bn) in 2013; +16.8% …
Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=106047.
Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/vietnam-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.
No comments:
Post a Comment